Pharmasset, a pharmaceutical firm focused on development of antiviral drugs, has named Kurt Leutzinger as its chief financial officer.

Leutzinger was CFO of Aggenix from 1997 to 2004.

Pharmasset also named Mark Meester as vice president of accounting and administration. He comes to Pharmasset from Mirus Bio where he served as director of operations.